Induction of the apoptosis inhibitor ARC by Ras in human cancers

Lily Wu1, Young-Jae Nam, Gloria Kung

  • 1Department of Medicine, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Insights

Ras signaling pathways activate apoptosis repressor with caspase recruitment domain (ARC) in epithelial cancers. ARC promotes cancer cell survival and proliferation, highlighting its role in oncogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Apoptosis inhibition is crucial for cancer development.
  • Apoptosis repressor with caspase recruitment domain (ARC) inhibits programmed cell death pathways.
  • ARC is upregulated in epithelial cancers, conferring resistance to cell death.

Purpose of the Study:

  • To investigate the mechanisms regulating ARC induction in cancer.
  • To determine the role of Ras signaling in ARC expression and function.
  • To elucidate ARC's contribution to Ras-mediated oncogenesis.

Main Methods:

  • Overexpression of activated Ras (N-Ras, H-Ras) in cell lines.
  • Transgenic mouse models with activated H-Ras.
  • Knockdown of endogenous N-Ras in cancer cells.
  • Analysis of ARC mRNA and protein levels.
  • Luciferase reporter assays to assess promoter activity.
  • Ubiquitination and proteasomal degradation assays.

Main Results:

  • Ras activation (N-Ras, H-Ras) increases ARC mRNA and protein levels via transcriptional activation and enhanced protein stability.
  • Ras signaling upregulates ARC in normal mammary epithelium and in Ras-induced tumors.
  • N-Ras knockdown reduces ARC levels in breast and colon cancer cells.
  • Ras stabilizes ARC protein by inhibiting its polyubiquitination and proteasomal degradation.
  • ARC mediates Ras-induced cell survival and cell cycle progression.

Conclusions:

  • Ras signaling is a key driver of ARC induction in epithelial cancers.
  • ARC contributes to the pro-survival and proliferative effects of Ras in cancer.
  • Targeting the Ras-ARC axis may offer therapeutic strategies for epithelial cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...